Susquehanna International Group, LLP Vanda Pharmaceuticals Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 83,280 shares of VNDA stock, worth $383,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,280
Previous 166,002
49.83%
Holding current value
$383,087
Previous $937,000
58.38%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding VNDA
# of Institutions
159Shares Held
45.2MCall Options Held
165KPut Options Held
33.6K-
Black Rock Inc. New York, NY8.14MShares$37.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.01MShares$18.5 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$16.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.8 Million0.94% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$10.4 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $260M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...